MIRA
MIRA Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.76
+3.27%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-116.1%
Return on equity
-115.6%
Return on assets
-115.2%
Return on invested capital
0.00x
Asset turnover
-$4.6M
Cash from operations
$0.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026